Brain implant learns to read OCD signals in tiny pilot study

NCT ID NCT03457675

Ongoing Knowledge-focused Sponsor: Baylor College of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This early study tests an adaptive deep brain stimulation (aDBS) system in 2 people with severe, treatment-resistant OCD. The device records brain signals to identify patterns linked to OCD distress and stimulation side effects. The goal is not to treat OCD now, but to gather data needed to build a future system that automatically adjusts stimulation for better symptom control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Deep brain stimulation (DBS) device
What this could lead to: If successful, this could pave the way for a smarter DBS system that automatically adjusts stimulation to better control OCD symptoms and reduce side effects.
What could go wrong: This is a very early, tiny study with only 2 participants, focused on gathering data rather than proving treatment works. The approach may not lead to a usable system.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL TREMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

essential tremor obsessive-compulsive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBSESSIVE-COMPULSIVE DISORDER

Contacts and locations

Locations

Baylor College of Medicine

Houston, Texas, 77030, United States
Brown University

Providence, Rhode Island, 02912, United States
University of Pittsburgh

Pittsburgh, Pennsylvania, 15260, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.